Grenada
Tuberculosis profile
Population  2013 <1 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 1.1 (1–1.1)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) <0.01 (<0.01–0.014) 7.5 (3.4–13)
Incidence  (includes HIV+TB) <0.01 (<0.01–<0.01) 4.1 (3.3–4.8)
Incidence (HIV+TB only)        
Case detection, all forms (%)        
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.3–3.1) 14 (4.7–22)
MDR-TB cases among notified pulmonary
TB cases
  (–) 0 (0–0)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed      
Pulmonary, clinically diagnosed      
Extrapulmonary      
       
Total new and relapse      
Previously treated, excluding relapses 1    
Total cases notified 1    
Among 1 new and relapse cases:
 cases aged under 15 years;
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 0   0
Laboratory-confirmed RR-/MDR-TB cases     0
Patients started on MDR-TB treatment      
TB/HIV 2013 Number (%)
TB patients with known HIV status 0 (0)
HIV-positive TB patients 0  
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB 19  
HIV-positive people provided with IPT 1  
Treatment success rate (%)
New and relapse cases registered in 2012 100
Previously treated cases, excluding relapse, registered in 2012  
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? No
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-04-26 Data: www.who.int/tb/data